98 related articles for article (PubMed ID: 8946585)
1. The pathogenic role of T lymphocytes in vasculitis.
Weyand CM; Goronzy JJ
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):217-20. PubMed ID: 8946585
[TBL] [Abstract][Full Text] [Related]
2. Giant cell vasculitis is a T cell-dependent disease.
Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM
Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981
[TBL] [Abstract][Full Text] [Related]
3. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.
Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology.
Wagner AD; Björnsson J; Bartley GB; Goronzy JJ; Weyand CM
Am J Pathol; 1996 Jun; 148(6):1925-33. PubMed ID: 8669478
[TBL] [Abstract][Full Text] [Related]
5. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes.
Weyand CM; Schönberger J; Oppitz U; Hunder NN; Hicok KC; Goronzy JJ
J Exp Med; 1994 Mar; 179(3):951-60. PubMed ID: 8113687
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
7. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis.
Ma-Krupa W; Jeon MS; Spoerl S; Tedder TF; Goronzy JJ; Weyand CM
J Exp Med; 2004 Jan; 199(2):173-83. PubMed ID: 14734523
[TBL] [Abstract][Full Text] [Related]
8. Giant cell arteritis.
Hunder GG
Lupus; 1998; 7(4):266-9. PubMed ID: 9643316
[TBL] [Abstract][Full Text] [Related]
9. Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.
Zhang H; Watanabe R; Berry GJ; Vaglio A; Liao YJ; Warrington KJ; Goronzy JJ; Weyand CM
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E970-E979. PubMed ID: 28115719
[TBL] [Abstract][Full Text] [Related]
10. Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis.
Weyand CM; Goronzy JJ
Curr Opin Rheumatol; 1995 Jan; 7(1):30-6. PubMed ID: 7718419
[TBL] [Abstract][Full Text] [Related]
11. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis.
Amoli MM; Gonzalez-Gay MA; Zeggini E; Salway F; Garcia-Porrua C; Ollier WE
J Rheumatol; 2004 Dec; 31(12):2413-7. PubMed ID: 15570643
[TBL] [Abstract][Full Text] [Related]
12. Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica.
Gonzalez-Gay MA
Arthritis Res; 2001; 3(3):154-7. PubMed ID: 11299056
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.
Andersson R; Hansson GK; Söderström T; Jonsson R; Bengtsson BA; Nordborg E
Clin Exp Immunol; 1988 Jul; 73(1):82-7. PubMed ID: 3048814
[TBL] [Abstract][Full Text] [Related]
14. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
15. Giant cell arteritis as an antigen-driven disease.
Weyand CM; Goronzy JJ
Rheum Dis Clin North Am; 1995 Nov; 21(4):1027-39. PubMed ID: 8592735
[TBL] [Abstract][Full Text] [Related]
16. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
González-Gay MA; Amoli MM; Garcia-Porrua C; Ollier WE
Semin Arthritis Rheum; 2003 Aug; 33(1):38-48. PubMed ID: 12920695
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in our understanding of giant cell arteritis pathogenesis.
Samson M; Corbera-Bellalta M; Audia S; Planas-Rigol E; Martin L; Cid MC; Bonnotte B
Autoimmun Rev; 2017 Aug; 16(8):833-844. PubMed ID: 28564617
[TBL] [Abstract][Full Text] [Related]
18. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.
Combe B; Sany J; Le Quellec A; Clot J; Eliaou JF
J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210
[TBL] [Abstract][Full Text] [Related]
19. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
Goronzy JJ; Xie C; Hu W; Lundy SK; Weyand CM
J Immunol; 1993 Jul; 151(2):825-36. PubMed ID: 8335912
[TBL] [Abstract][Full Text] [Related]
20. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.
Andersson R; Jonsson R; Tarkowski A; Bengtsson BA; Malmvall BE
Ann Rheum Dis; 1987 Dec; 46(12):915-23. PubMed ID: 2962542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
